900120.KQ CKH Food & Health Limited
- Market cap
- KRW 6.79B
- P/E
- 0.8x
- P/B
- 0.01x
- ROE
- 1.3%
- Dividend yield
- -
- Fundamental score
- 2.9/5
Ratios use the latest price and the fiscal year ending Jun 2026.
Is 900120.KQ undervalued?
Graham numberThe Graham number of CKH Food & Health Limited cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
CKH Food & Health Limited fundamental analysis
13 of 22 checks passedROE 0/2
Low return on equity (1.3%), below 10%.
ROA 0/1
Return on assets (1.3%) is below the industry median (1.3%).
Profit Consistency 2/2
Profitable for 5 consecutive years.
Earnings Growth 5Y 1/1
Earnings per share grew over the past 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 0/1
Earnings growth cannot be compared with the industry.
Revenue Growth 2/2
Revenue grew 408.2% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 2/2
Low debt to equity (0.1%), 40% or less.
Debt Trend 0/1
Debt to equity has risen over the past 5 years.
Debt Coverage 1/1
Operating cash flow covers 20% of total debt.
Interest Coverage 1/1
EBIT is 1,188.8x against interest expense, well covered.
PE vs Market 1/1
PE (0.8x) is below the market median (11.3x).
PE vs Industry 1/1
PE (0.8x) is below the industry median (5.6x).
PBV 1/1
Price to book (0.0x) is below the industry median (0.7x).
Graham Number 1/1
The price is below the Graham number (PE x PB = 0.0, limit 22.5).
PEG 1/1
PEG on 5-year earnings growth is 0.00, growth is cheap.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
CKH Food & Health Limited stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About CKH Food & Health Limited
CXI Healthcare Technology Group Limited engages in the manufacture and distribution of health foods. It provides Chinese medicine-based health supplements in capsule, tablet, drink, and tea forms. The company was formerly known as CKH Food & Health Limited and changed its name to CXI Healthcare Technology Group Limited in October 2023. CXI Healthcare Technology Group Limited was founded in 2009 and is based in Grand Cayman, the Cayman Islands.
Full company profileCKH Food & Health Limited financial statements
CKH Food & Health Limited annual financial statements (KRW; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 1.64B | 873M | 861M | 778M | 373M | 610M | 545M | 377M | 377M | 49.5B |
| Gross Profit | 785M | 312M | -4.37M | -37.1M | -67.3M | 127M | 153M | 149M | 162M | 11.8B |
| Operating Income | 389M | 18.2M | -453M | -438M | -590M | 26.4M | 33.9M | 36.7M | 102M | 2.99B |
| EBITDA | - | - | - | - | - | - | 31.7B | 31.5B | 54.0B | 38.7B |
| Net Income | 289M | 4.69M | -438M | -425M | -579M | 29.7M | 32.2M | 39.6M | 159M | 8.07B |
| EPS | 2.62 | 0.04 | -3.97 | -3.85 | -5.25 | 0.25 | 0.26 | 0.23 | 138 | 3,612 |
| Balance Sheet | ||||||||||
| Total Assets | 3.64B | 3.61B | 3.31B | 2.80B | 2.13B | 2.20B | 2.22B | 2.30B | 484B | 617B |
| Total Liabilities | 153M | 97.2M | 221M | 135M | 48.9M | 72.8M | 45.9M | 18.6M | 2.72B | 3.18B |
| Shareholders' Equity | 3.49B | 3.51B | 3.09B | 2.66B | 2.08B | 2.13B | 2.17B | 2.28B | 481B | 614B |
| Cash & Short-term Investments | 2.22B | 2.55B | 2.22B | 1.90B | 1.26B | 148M | 341M | 522M | 160B | 60.9B |
| Total Debt | - | - | - | - | - | 1.29M | - | - | - | - |
| Cash Flow | ||||||||||
| Operating Cash Flow | 339M | 54.3B | -57.4B | -58.1B | -44.3B | 8.72B | 36.0B | 175M | 229M | 38.7B |
| Capital Expenditure | 1.61M | 92.8M | 40.9M | 40.9M | 65.7B | 205B | 5.78M | 0.00 | 0.00 | 232B |
| Free Cash Flow | - | - | - | - | -110B | -196B | 36.0B | 31.6B | 43.7B | -193B |
| Ratios | ||||||||||
| ROE | 8.3% | 0.1% | -14.2% | -16.0% | -27.8% | 1.4% | 1.5% | 1.7% | 0.0% | 1.3% |
| ROA | 7.9% | 0.1% | -13.2% | -15.2% | -27.2% | 1.4% | 1.4% | 1.7% | 0.0% | 1.3% |
| Net Profit Margin | 17.6% | 0.5% | -50.9% | -54.6% | -155.3% | 4.9% | 5.9% | 10.5% | 42.3% | 16.3% |
| Debt to Equity | - | - | - | - | - | 0.00x | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
CKH Food & Health Limited dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Jun 28, 2012
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | - | - | - |
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
| 2019 | - | - | - |
| 2018 | - | - | - |
| 2017 | KRW 7.75M | 0.07 | 165.3% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:5 on Oct 6, 2026.
Who owns CKH Food & Health Limited
- Insiders 8.22%
- Institutions 0.00%
- Public & others 91.79%
- Shares outstanding 2.23M
- Free float 68.6K
CKH Food & Health Limited company profile
- Company name
- CKH Food & Health Limited
- Ticker
- 900120.KQ
- ISIN
- KYG2114A1094
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Personal Care Products
- Employees
- 26
- Fiscal year end
- June
- Address
- Cricket Square, Grand Cayman, Cayman Islands, KYI-1103
- Phone
- 86 591 8803 1033
- Website
- ckhfnh.co.kr
About CKH Food & Health Limited
CXI Healthcare Technology Group Limited engages in the manufacture and distribution of health foods. It provides Chinese medicine-based health supplements in capsule, tablet, drink, and tea forms. The company was formerly known as CKH Food & Health Limited and changed its name to CXI Healthcare Technology Group Limited in October 2023. CXI Healthcare Technology Group Limited was founded in 2009 and is based in Grand Cayman, the Cayman Islands.
CKH Food & Health Limited management
4- Mr. Jin Sheng LinCEO & Director · born 1963
- Mr. Yaorong GuoDirector & Director · born 1949
- Mr. Jungao LyuDirector & Director · born 1980
- Mr. Ben Zheng LiuDirector & Director · born 1979